Latest standard for routing e-prescriptions supports Meaningful Use Stage 2 Incentive Program
South San Francisco, CA – February 20, 2014 – First Databank (FDB), a leading provider of integrated drug knowledge, today announced the company’s proprietary solution for effective medication reconciliation, FDB MedsTracker, has received certification from Surescripts for prescription routing in adherence with the NCPDP SCRIPT 10.6 standard required for Meaningful Use Stage 2 certification. FDB MedsTracker was previously certified on the Surescripts 4.2 routing standard and has been used for electronic prescribing in hospitals since 2010.
Certification testing was performed on FDB MedsTracker, version 6, which is the most advanced version designed to support the required elements specified in Meaningful Use, Stage 2 certification. Surescripts’ Prescription Routing service allows prescribers to securely send a prescription electronically to the patient’s preferred retail or mail-order pharmacy. In turn, pharmacies can use this service to send prescription renewal authorization requests directly to the prescriber.
FDB MedsTracker has demonstrated immediate and measurable improvements in the medication reconciliation process. Notable advances reported by customers include increased accuracy of home medication lists; efficiency of discharge medication orders and electronic prescribing; reductions in missed medications, duplicate therapies, and incorrect dosing; and workflow efficiencies with measurable time savings for clinicians.
Interested parties may learn more about FDB MedsTracker at the upcoming HIMSS14 Conference, February 23 – 27, Orlando, Florida, by attending a special medication reconciliation presentation during the Interoperability Showcase, February 26 at 12:30 pm, by visiting the FDB booth #1965, or by contacting FDB directly at 800-633-3453.
About First Databank (FDB)
First Databank (FDB) provides drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication decision support category, we offer more than three decades of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes. For a complete look at our solutions and services please visitwww.fdbhealth.com or follow us on Twitter and LinkedIn.
About Hearst Health
FDB is part of the Hearst Health network, which also includes Zynx Health, MCG (formerly Milliman Care Guidelines) and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 20 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.
© 2014 First Databank, Inc. Part of the Hearst Health network. All trademarks mentioned herein are the properties of their respective owners.